Negligible Impact of Thiopurine Exposure on Immunogenicity to Infliximab in the Setting of Elevated Infliximab Concentrations
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Inflammatory Bowel Diseases
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Impact of Thiopurine Exposure on Immunogenicity to Infliximab Is Negligible in the Setting of Elevated Infliximab Concentrations
Inflamm. Bowel Dis. 2022 Mar 30;28(4)649-651, RC Ungaro, JF Colombel, MC Dubinsky, A Jain, T DervieuxFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.